Discover other firms ranked in Private Equity: Buyouts: High-end Capability

1
Band 1
Simpson Thacher & Bartlett LLP
1
Simpson Thacher & Bartle…
5 Years Ranked

View profile
2
Band 2
2
Latham & Watkins LLP
6 Years Ranked

View profile
Paul, Weiss, Rifkind, Wharton & Garrison LLP
2
Paul, Weiss, Rifkind, Wh…
5 Years Ranked

View profile
2
Latham & Watkins LLP
6 Years Ranked

View profile
3
Band 3
Vinson & Elkins LLP
3
Vinson & Elkins LLP
2 Years Ranked

View profile
Davis Polk & Wardwell LLP
3
Davis Polk & Wardwell LLP
4 Years Ranked

View profile
Willkie Farr & Gallagher LLP
3
Willkie Farr & Gallagher…
4 Years Ranked

View profile

Chambers Review

Provided by Chambers

Private Equity: Buyouts: High-end Capability - USA

2
Band 2

What the Team is Known For

Debevoise & Plimpton LLP is experienced in a significant array of US and cross-border buyouts, often working with high-level funds and target corporations. Brings to bear an integrated global practice, able to provide support in areas such as tax, litigation and corporate governance. Demonstrates considerable strength in the healthcare sector, with notable experience handling investments into drug, device and wider consumer product manufacturers.

Strengths

"Debevoise are very commercially-minded and have excellent M&A and financing capabilities."
"They have a very good private equity offering, and have a lot of experience working with sponsors."
"Debevoise are very efficient. They offer strong quality and have a good turnaround."

Work Highlights

Debevoise & Plimpton LLP advised Clayton Dubilier & Rice and TPG Capital in their acquisition of all outstanding shares of Covetrus.

Notable practitioners

New York-based Kevin Schmidt is a key contact.